Get started

Telehealth

HIMS & HERS Weekly ProjectionGood evening traders. Waiting on 1st reactionary zone to be tested at the $5.55'ish area based off the weekly chart. After a long bullish move up for several weeks, this is considerably a healthy pullback. On the monthly time frame, however, there is an OB VOID taking HIMS all the way back down to the mid $4's. Considering DJI and SPX have now turned into huge sellers, HIMS has held rather nicely on numerous occasions. Only time will tell. Overall, waiting to average down if and when the market reaches mid 4's. Other than that, enjoy the rest of your weekend everyone and remember. Happy Trading!!!
NYSE:HIMSLong
by Vic_Tech_Trader
TLMD - CHANNEL BOTTOM + FALLING WEDGE = BOOM GOES THE DYNAMITEAll, This is a crazy crazy setup. WW here for sure. Needs to hold this bottom. Easily worth taking a long here stop loss or not. Id probably not take a stop loss because sooooo many times it dips below all time low and support bottom falls 5-10% then moons. Happens literally all the time. I know not a high volume stock, but if this is right you can long hold for at least 20-40% gain if not more. MUST hold support and/or small dip under otherwise invalidated. HOWEVER following the falling wedge fails as well dips down and STILL in the falling wedge is fine just follow the # of attempts hitting falling wedge wall afte 3 rejections should be end of that. So either way this setup will blow up soon or easy to follow after.
TLong
by DigitalData
Teladoc Trade [TDOC]A staple of Cathie Wood's ARKK Invest fund, Teladoc looks to be winding up for a big move in the coming days after breaking the resistance of a supply line that has kept TDOC stagnant since the peak of its small rally in June. Now we find it at a key support level just outside of the trendline and finding support on our 21 MA as well. I am long on TDOC with a stop loss at $149.99. At this point, if the green horizontal line of support would be broken, the next level we want to look at for a long would be $146.84. However, a break and close of $146 would be a break into my no trade zone. Bonus points for the asset if it can hold and maintain price action outside of our green, downward sloping line of resistance now hopefully flipped support.
NYSE:TDOCLong
by TradeVibez
CloudMD $DOC.V - Months of selling and consolidation done?CloudMD has been under selling pressure for months now. Today it closed its Vision Pros Acquisition and is expected to close its largest acquisition - Oncidium this month as well. The company can boast a 125-130mil revenue run rate. Vision Pros adds 22 mil in rev and 10% EBITDA margins to the bottom line for CloudMD. I have a position in this company. It has not been an easy 3-4 months. The rest of the week will prove out if this was a one and done green day yesterday or if buyers are serious and ready to take control again. PT on DOC is $3.96. Was a "top pick" on Bloomberg MarketCall June 23rd. At some point the market is going to start respecting that revenue and positive EBITDA that the company is set to report for this full fiscal year. currently trading at 3x sales. This should definitely be on the watchlist now. Look to see Buyers control Price around the 2SD Cross as highlighted. DCA approach the play here. DOC.V is a long hold for myself. Hope the chart and thoughts help. Please do you own DD and follow your own trading rules. Cheers, Luke
DLong
by LeBelleChart
3
Teladoc Health Ready For A Rally! 🩺TDOC had a massive $133 correction since February 16th. They reported an earnings of -$3.07 which missed estimates of $0.24. Big miss on their earnings accompanied with a correction in the overall market resulted in price landing below $200. The past 4 days TDOC reached a low of $174 and today managed to test the $200 support but failed to get above. I have entered 4/16 $220 calls at close today avg $ of $7.15. Will look to add more TDOC swings on continued show of strength. Over $200/202 TDOC can make a move back to $220 quickly if the market holds up. Chart: HVN: HVN at ~$195 serving as a strong support zone. This is where TDOC can chop around at if it isn’t ready to break $201/202 lvl yet. HVN at $217/220 area serves as first PT. Fib: Fib retracement lvls at $201.5 and $222 serving as good entries/exits. Support/Resistance: Resistance levels roughly at $200,210, 216, and 221 lvls to play off of as well. EMA’s: 20 EMA will be right at 223 on the Daily chart MACD & RSI: both are gearing up for reversals Plan: I entered a smaller position and would like to add heavier on confirmation of a move back to $220 PT. SL: Will be watching $188-$190 lvl to hold as support for SL if we re-trace. Current AH price action has TDOC above $200 but lets see what it does Friday.
NYSE:TDOCLong
by DOpeTrades
BREAKOUT ALERT!This chart is ready for breakout! the stock is ISWH. they are in to bitcoin mining, telehealth and renewable energy. has a decent share structure. On technicals, this is clearly oversold as evidenced by the stoch rsi and macd; it also held the support really well (red line). This area is where i would scale in, and a break of that 0.26 is my bullish confirmation. As far as Eliot Waves, I strongly think it's setting up for the wave 3. a good catalyst could break that 0.45 resistance and with the tiny share structure, I have no doubt this would reach its 52 week high $1.40 This is a SWING to dollar land! RISK WHAT YOU CAN AFFORD TO LOSE! DISCLAIMER: Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks and options may fluctuate, and, as a result, clients may lose more than their original investment. In any trading or Investing, a due diligence is a must.
ILong
by Sniper29x
Unheard gross margins of 95% and a $800B TAM : $GDRXGoodRx is a free-to-use service that allows Americans to find the lowest-cost prescription drugs in their area. The company makes money by receiving a commission for every prescription order filled via its coupons, which are accepted by nearly all 70,000 pharmacies across the country. -Most Downloaded medical app in US with 4.8/5 rating(700,000+ reviews) -Partnership with Kroger -Competing with TDOC with the launch of HeyDoctor - Rising prices of pharmaceuticals and their mission is to lower the cost of healthcare -95% Gross margin (What?!?!). 30% Operating margin. - $75M Free cash flow. - TAM $800 Mn - NPS 86 - 4.6/5 Glassdoor - Founder led Concerns, 1. P/S of 37.1 and 201 PE. Average PE in healthcare is 24. 2. IPO hype(good for trades though) 3. 94% of top line revenue still coming in from prescription stream(concentration risk?) which grew 42% Q1. 4. Regulations 5. International expansion? 6. 4 holders own 60-65% of the company(Both good and bad) TA, 1. Wedge breakout 2. Potential base of Cup. 3. Low volume on Pullback Not a long term position yet. Swing trade. Entry : break of 52 Stop loss : 49 (-7.8%)
NASDAQ:GDRXLong
by ashainp
2